The Future of Nuclear Medicine: Advancing Precision Oncology and Healthier Cities

Healthcare is entering a new era — one where diagnosis is becoming more precise, treatments are increasingly personalized, and medical innovation is reshaping the future of patient care. At the heart of this transformation is nuclear medicine, a field that combines molecular imaging, radiopharmaceutical science, and targeted therapies to improve clinical decision-making and patient outcomes.

Unlike conventional imaging, nuclear medicine allows clinicians to visualize biological processes at the molecular level. Technologies such as PET/CT and SPECT provide insights that support earlier diagnosis, more accurate disease staging, treatment planning, and response assessment. These capabilities are particularly valuable in oncology, where timely and precise information can directly influence patient outcomes.

The rapid development of theranostics represents one of the most exciting advances in modern medicine. By pairing molecular imaging with targeted radionuclide therapy, theranostics enables clinicians to identify suitable patients and deliver personalized treatments using the same biological target. This approach is redefining cancer care and expanding therapeutic possibilities for patients worldwide.

At the same time, artificial intelligence, quantitative imaging, and next-generation radiopharmaceuticals are accelerating innovation across nuclear medicine. These technologies are improving image quality, supporting clinical workflows, and creating new opportunities for precision healthcare.

Beyond hospitals, healthcare is also influenced by the environments in which people live. Urbanization, air pollution, transportation systems, and environmental exposures all affect population health. Building healthier cities requires collaboration among healthcare professionals, researchers, engineers, urban planners, and policymakers. Scientific evidence should guide decisions that promote healthier communities alongside advances in clinical medicine.

Through this publication, I will share evidence-based perspectives on nuclear medicine, molecular imaging, radiopharmaceutical innovation, radiation safety, precision oncology, health technology, and urban health. My goal is to translate scientific knowledge into accessible insights that encourage collaboration, critical thinking, and innovation.

Scientific progress is most meaningful when it improves patient care, informs public health, and contributes to healthier societies. I hope these articles provide value to clinicians, researchers, students, and anyone interested in the future of healthcare.

Thank you for joining me on this journey.

Amirhossein Hajigol, PhD Researcher in Nuclear Medicine & Medical Radiation Sciences